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SUMMARY 
50 manic patients of unipolar and bipolar affective illness were placed on oral lithium 600-1500 mg 
daily and serum levels in the range of 0.49-1.23 mEq/L. Abetter response in bipolar disorders than uni-
poiar was observed. Besides, a much better response to lithium therapy is observed in patients with disease 
of longer duration and a positive history of affective illness in blood relations. Therapeutic effect had no 
relationship in terms of age or sex of the patients. 
The western medical literature is re-
plete with studies related to role of lithium 
in affective disorders (Davis, 1967 ; Fieve 
et al., 1976). On the contrary studies on 
lithium in Indian subjects are still not so 
common. In recent years many workers 
have explored different aspects of lithium 
treatment (Ghosh et al., 1977 ; Narayanan 
et al., 1977 ; Venkoba Rao and Harihara 
subramanium, 1978, Prakash et al., 1978). 
However, the subject is still unexplored in 
many aspects and gives profound scope of 
research. 
Several factors influence response to 
lithium. These include pharmacokinetic 
factors relating to dose and serum con-
centration, its absorption and excretion and 
the clinical variables like age, sex, nature of 
illness, total duration of illness and a family 
history (Ananth, 1977). The present study 
is aimed to evaluate efficacy of lithium in 
relation to the above factors. 
MATERIAL AND METHODS 
The sample of this study was obtained 
from patients attending the Psychiatric 
unit of S. R. N. Hospital Allahabad, during 
February 1979 to January 1980. A total 
number of 50 patients suffering from affect-
ive illness (Unipolar and Bipolar) formed 
the material. Of these 50, 23 were hospital-
ized and the rest were attending Psychiatric 
OPD. Their ages ranged between 16 and 
65 years. 
After the initial diagnosis of affective 
psychosis, the cases were subjected to a 
detailed history, physical examination and 
a battery of investigations to exclude any 
evidence of cardiac or renal disease. Pre-
sence of renal or cardiac illness, pregnancy 
and lactation have been taken as contra-
indications to lithium therapy. Investiga-
tions included : Urine examination, Blood 
urea, Blood sugar and Electrocardiogram. 
Psychometric assessment was done on a 
24 point Hamilton Rating Scale for de-
pression (1960) and 17 point Beigel's Rating 
Scale for mania (Beigel et al., 1971). Rating 
on these scales was repeated on subsequent 
follow up visits to assess the improvement. 
All the patients were started on lithium 
Carbonate 500-750 mg per day after blood 
samples for haemogram (Hb. TLC, DLC). 
Two days after the commencement of 
lithium then or. weekly and later at longer 
intervals serum lithium was estimated by 
flame photometry using Amdisen's method 
(Amdisen, 1967). The blood sample for 
serum lithium estimation were drawn twelve 
hours after the last dose of lithium. The 
dose was increased by 150-250 mg every 
2nd or 3rd day till the desired effect was 
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obtained and without any observable side 
effects. Serum lithium level was maintained 
at a level below the 1.6m Eq/L. The main-
tenance dose ranged between 600-900 
mgm per day. 
RESULTS 
The present sample consists of 50 
patients of affective illness on lithium treat-
ment, which included 24 cases of mania, 
18 cases of depression and 8 cases of MDP. 
50% of the cases had been ill for the past 
1-5 years, 36% for more than 6 years and 
the rest 14% reported that their illness was 
of less than a year's duration. 
Table 1 shows mean serum lithium 
concentration at different oral doses. In 
the majority of subjects lithium was given 
in dosage of 600 to 1200 mg daily. At 
maximum dose of 1500 mg/day the mean 
lithium concentration was 1.23 mEq/L. 
Pre-treatment psychometric assessment 
for manic states shows mean manic score of 
19.60 and 14.36 for unipolar and bipolar 
respectively. After treatment with lithium 
the mean score was observed below 2. 
Similarly a marked reduction of depressive 
score was noticed in depressive patients 
after the lithium therapy (Table II). A 
higher percentage reduction in manic scores 
was observed than in depression. A raaxi-
TABLE I—Oral odse and Serum Lithium Con-
centration 
Dose of Serum Lithium No. of 
Lithium concentration values 
(in mgm) (Mean) mEg/L 
Range 
450 
500 
600 
750 
900 
1000 
1050 
1200 
1250 
1350 
1500 
Total 
0.32+0.06 
0.40+0.06 
0.49+0.04 
0.73+0.08 
0.78+0.09 
0.93+0.07 
0.94+0.09 
1.07+0.08 
1.07+0.93 
1.15+0.85 
1.23+0.087 
0.32—1.23 
5 
6 
14 
18 
17 
21 
34 
22 
14 
11 
7 
179 
0.25—0.4 
0.30—0.46 
0.40—0.54 
0.54—0.82 
0.58—0.94 
0.77—1.06 
0.75—1.14 
0.95—1.20 
0.90—1.24 
0.96—1.28 
1.12—1.34 
0.25—1.34 
mum reduction of mean scores was found 
in the manic phase of bipolar illness (93.0%). 
The response to lithium was assessed 
on the basis of percentage reduction in total 
scores after one month of treatment with 
the drug. On the basis of response demon-
strated by these subjects they were cate-
gorised into the following three groups— 
Group I—(Good responders) 
Reduction in score was more than 90%. 
TABLE II—Mean values of scores of Hamilton rating scale (depression) and Beigel's rating scale 
(mania 
Unipolar : 
Mania (N=24) 
Depression (N = 18) 
Bipolar 
Manic Phase (N=4) 
Depressive (N=4) 
Pretreatment 
Phase 
19.6+4.3 
26.8±9.6 
14.3+2.6 
25.5+4.2 
Number of days after lithium treatment % reduction 
7 
days 
12.0+2.7 
18.7+6.5 
9.3+1.7 
13.8+2.9 
14 
days 
5.9+3.10 
13.3+5.2 
3.8+1.7 
11.5+3.9 
30 
days 
3.20+2.2 
9.30+6.1 
1.0+0.7 
6.2+2.5 
more than score at 30 
1 month days from 
pre-treat-
ment phase 
1.7+1.6 83.5 
3.6+1.8 65.2 
1.0+0.7 93.0 
4.7+1.0 75.5 60  A. K. TANDON et. al. 
Group II—(Moderate responders) 
Reduction in score was 70 to 90%. 
Group III—(Poor responders) 
Reduction was less than 70% or those 
who did not respond at all. 
Rating of the subjects in terms of their 
response revealed that 26% of the sample 
could be labelled as good responders, 52% 
as moderate responders and 22% poor 
responders. A better response was observed 
in patients with longer duration of illness. 
All the cases who were suffering from the 
illness for more than 6 years duration res-
ponded except one. The analysis of response 
in relation to family history showed a higher 
incidence of good responders in patients 
with a similar psychiatric illness in blood 
relations (Table III). 
TABLE III—Response to lithium in relation to 
different factors 
SI. Variables 
No. 
Response 
Gr. I 
(GR) 
Gr. II 
(MR) 
Gr. Ill 
(PR) 
N  % N  % N % 
1. Type of affective Illness 
Mania (N=24) 9 37.5 12 50.0 3 12.5 
Depression 
(N=18) 2 11.1 8 44.4 8 44.4 
M.D.P.(N=8) 2 25.0 6 75.0 .. 
2. Sex 
Male(N=44) 11 25.0 22 50.0 11 25.0 
Female (N=6) 2 33.3 4 66.7 .. 
3. Duration of Illness (inyrs.) 
Less than 1 
(N=7) 1 14.3 3 42.8 3 42.8 
lto5(N=25) 3 12.0 15 60.0 7 28.0 
6tol0(N=7) 4 57.1 2 28.6 1 14.3 
More than 10 
(N=ll)  5 45.5 6 54.5 .. 
5. History of Rsychiatric illness in blood Relations 
Present (N-=20) 7 35.0 11 55.0 2 10.0 
Absent (N=30) 6 20.0 15 50.0 9 30.0 
DISCUSSION 
In the present series, 50 patients of 
unipolar an I bipolar affective illness, 44 
males and 6 females were placed on oral 
lithium in a dose of 600-1500 mg daily 
after proper psychometric assessment on 
respective scales for mania and depression. 
Regulation of lithium dosage was done by 
monitoring its concentration in the blood 
at regular intervals and careful observation 
for appearance of serious side effects. 
Majority of the patients (94%) showed 
significant improvement. Only three 
patients who were suffering from recurrent 
depression did not show any response and 
one relapsed after stopping the medication. 
The incidence of non-responders (6%) in 
comparable, to Misra and Burns (1977) 
and Prakash et al. (1978), who observed 
non responders as 8.4% and 9.09% res-
pectively in their reports. The dose of the 
lithium required to achieve remission in 
our patients was lesser in comparison to 
western countries. In other words effective 
serum concentration (0.6—1.2 mEq/L.) was 
achieved with lesser amounts of lithium 
carbonate (750—1500 mg/day) than that 
required in western population (900— 
1800 mg/day), suggesting thereby a racial 
factor. 
In the light of observations of the pre-
sent study lithium can be said to have better 
therapeutic effect in bipolar than unipolar 
illness and amongst unipolar, in manics 
than depressives. Positive correlation of 
response in relation to type of affective ill-
ness coincides with reports of other workers 
(Gershon and Yuwiller, 1960, Venkoba 
Rao and Hariharasubramaniam, 1978). A 
better beneficial effect was a feature in 
patients, who had a history of affective 
illness in blood relations (35% v.s. 20%). 
Several investigators (Mendelwicz et al., 
1972 ; Prien et al., 1972 and Ghosh et al., 
1977) have also reported a positive corre-
lation between response and presence of 
affective illness in first degree relatives. LITHIUM TREATMENT IN AFFECTIVE DISORDERS  61 
The present study revealed a higher 
incidence of good responders with increas-
ing duration of illness. None of the patients, 
with a duration of more than 10 years, 
illness failed to respond with this treatment. 
Venkoba Rao and Hariharasubramaniam 
(1978) also observed a similar finding but 
Schou et al. (1967) reported that there was 
no association between response and dura-
tion of illness. 
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